Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation

Vitamin K, especially its K2 form, is considered to be a protective factor against developing vascular changes and bone lesions that are common complications in kidney transplant (KTx) recipients. There is a growing number of studies showing that KTx patients are at risk of vitamin K deficiency. The...

Full description

Bibliographic Details
Main Authors: Małgorzata Kluch, Patrycja Bednarkiewicz, Magdalena Orzechowska, Piotr Grzelak, Ilona Kurnatowska
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/23/5070
_version_ 1797462473783115776
author Małgorzata Kluch
Patrycja Bednarkiewicz
Magdalena Orzechowska
Piotr Grzelak
Ilona Kurnatowska
author_facet Małgorzata Kluch
Patrycja Bednarkiewicz
Magdalena Orzechowska
Piotr Grzelak
Ilona Kurnatowska
author_sort Małgorzata Kluch
collection DOAJ
description Vitamin K, especially its K2 form, is considered to be a protective factor against developing vascular changes and bone lesions that are common complications in kidney transplant (KTx) recipients. There is a growing number of studies showing that KTx patients are at risk of vitamin K deficiency. The aim of this study was to evaluate the intake of vitamin K1 and K2 in the diet of patients in the late period after KTx. During a routine visit at one outpatient transplantation clinic in Central Europe, a diet survey questionnaire was filled in by 151 clinically stable KTx recipients and compared with medical history, anthropometric measurements and laboratory tests. Mean vitamin K1 intake was 120.9 ± 49 μg/day and vitamin K2 (MK, menaquinone) intake 28.69 ± 11.36 μg/day, including: MK-4: 25.9 ± 9.9 μg/day; MK-5: 0.1 ± 0.2 μg/day; MK-6: 0.2 ± 0.4 μg/day; MK-7: 0.2 ± 0.23 μg/day; MK-8: 1 ± 1.9 μg/day; MK-9: 0.9 ± 2.3 μg/day; and MK-10: 0.2 ± 0.5 μg/day. Our study showed that KTx recipients’ diets contained adequate amounts of vitamin K1, whereas the intake of vitamin K2 seemed insufficient.
first_indexed 2024-03-09T17:37:59Z
format Article
id doaj.art-b7440e4eaa124d3aa8e738eb8a16869b
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T17:37:59Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-b7440e4eaa124d3aa8e738eb8a16869b2023-11-24T11:51:38ZengMDPI AGNutrients2072-66432022-11-011423507010.3390/nu14235070Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney TransplantationMałgorzata Kluch0Patrycja Bednarkiewicz1Magdalena Orzechowska2Piotr Grzelak3Ilona Kurnatowska4Department of Diagnostic Imaging, Polish Mother’s Memorial Hospital Research Institute, 93-338 Lodz, PolandDepartment of Internal Medicine and Transplant Nephrology, Medical University of Lodz, 90-153 Lodz, PolandDepartment of Molecular Carcinogenesis, Medical University of Lodz, 90-752 Lodz, PolandDepartment of Diagnostic Imaging, Polish Mother’s Memorial Hospital Research Institute, 93-338 Lodz, PolandDepartment of Internal Medicine and Transplant Nephrology, Medical University of Lodz, 90-153 Lodz, PolandVitamin K, especially its K2 form, is considered to be a protective factor against developing vascular changes and bone lesions that are common complications in kidney transplant (KTx) recipients. There is a growing number of studies showing that KTx patients are at risk of vitamin K deficiency. The aim of this study was to evaluate the intake of vitamin K1 and K2 in the diet of patients in the late period after KTx. During a routine visit at one outpatient transplantation clinic in Central Europe, a diet survey questionnaire was filled in by 151 clinically stable KTx recipients and compared with medical history, anthropometric measurements and laboratory tests. Mean vitamin K1 intake was 120.9 ± 49 μg/day and vitamin K2 (MK, menaquinone) intake 28.69 ± 11.36 μg/day, including: MK-4: 25.9 ± 9.9 μg/day; MK-5: 0.1 ± 0.2 μg/day; MK-6: 0.2 ± 0.4 μg/day; MK-7: 0.2 ± 0.23 μg/day; MK-8: 1 ± 1.9 μg/day; MK-9: 0.9 ± 2.3 μg/day; and MK-10: 0.2 ± 0.5 μg/day. Our study showed that KTx recipients’ diets contained adequate amounts of vitamin K1, whereas the intake of vitamin K2 seemed insufficient.https://www.mdpi.com/2072-6643/14/23/5070kidney transplantationvitamin Kdiet
spellingShingle Małgorzata Kluch
Patrycja Bednarkiewicz
Magdalena Orzechowska
Piotr Grzelak
Ilona Kurnatowska
Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
Nutrients
kidney transplantation
vitamin K
diet
title Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
title_full Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
title_fullStr Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
title_full_unstemmed Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
title_short Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation
title_sort vitamin k1 and k2 in the diet of patients in the long term after kidney transplantation
topic kidney transplantation
vitamin K
diet
url https://www.mdpi.com/2072-6643/14/23/5070
work_keys_str_mv AT małgorzatakluch vitamink1andk2inthedietofpatientsinthelongtermafterkidneytransplantation
AT patrycjabednarkiewicz vitamink1andk2inthedietofpatientsinthelongtermafterkidneytransplantation
AT magdalenaorzechowska vitamink1andk2inthedietofpatientsinthelongtermafterkidneytransplantation
AT piotrgrzelak vitamink1andk2inthedietofpatientsinthelongtermafterkidneytransplantation
AT ilonakurnatowska vitamink1andk2inthedietofpatientsinthelongtermafterkidneytransplantation